JOINT MD™ – RELIEF STARTS UP TO 3x FASTER!
*Subjects in glucosamine trials typically report positive results after 6 weeks, on average. Subjects in testing of the key ingredient (IgG HyperImmune micronutrient peptide) in Joint MD™ initially reported positive results after two weeks. Joint MD™ is covered by U.S. patent #5,650,175 and is patent-pending. Formulated by a medical doctor employed by Iomedix